139 related articles for article (PubMed ID: 3668521)
1. Modification of dopamine and norepinephrine metabolism in the rat brain by monoamine oxidase inhibitors.
Buu NT; Angers M; Duhaime J; Kuchel O
J Neural Transm; 1987; 70(1-2):39-50. PubMed ID: 3668521
[TBL] [Abstract][Full Text] [Related]
2. Effects of different monoamine oxidase inhibitors on the metabolism of L-dopa in the rat brain.
Nguyen TB; Angers M
Biochem Pharmacol; 1987 May; 36(10):1731-5. PubMed ID: 3109430
[TBL] [Abstract][Full Text] [Related]
3. Consequences of monoamine oxidase inhibition: increased vesicular accumulation of dopamine and norepinephrine and increased metabolism by catechol-O-methyltransferase and phenolsulfotransferase.
Buu NT; Lussier C
Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(3-4):563-8. PubMed ID: 2748880
[TBL] [Abstract][Full Text] [Related]
4. Modification of vesicular dopamine and norepinephrine by monoamine oxidase inhibitors.
Buu NT
Biochem Pharmacol; 1989 May; 38(10):1685-92. PubMed ID: 2730683
[TBL] [Abstract][Full Text] [Related]
5. Relationship between catechol-O-methyltransferase and phenolsulfotransferase in the metabolism of dopamine in the rat brain.
Buu NT
J Neurochem; 1985 Nov; 45(5):1612-9. PubMed ID: 3930664
[TBL] [Abstract][Full Text] [Related]
6. Comparison of short and long-lasting effects of pargyline on cerebral dopamine metabolism.
Waldmeier PC; Maître L
Naunyn Schmiedebergs Arch Pharmacol; 1976 Aug; 294(2):133-40. PubMed ID: 1012333
[TBL] [Abstract][Full Text] [Related]
7. Different metabolism of norepinephrine and epinephrine by catechol-O-methyltransferase and monoamine oxidase in rats.
Eisenhofer G; Finberg JP
J Pharmacol Exp Ther; 1994 Mar; 268(3):1242-51. PubMed ID: 8138937
[TBL] [Abstract][Full Text] [Related]
8. Effect of high single doses of levodopa and carbidopa on brain dopamine and its metabolites: modulation by selective inhibitors of monoamine oxidase and/or catechol-O-methyltransferase in the male rat.
Männistö PT; Tuomainen P
Naunyn Schmiedebergs Arch Pharmacol; 1991 Oct; 344(4):412-8. PubMed ID: 1766471
[TBL] [Abstract][Full Text] [Related]
9. Dopamine produced from L-DOPA is degraded by endogenous monoamine oxidase in neurons of the dorsal raphe nucleus of the rat: an immunohistochemical study.
Arai R; Karasawa N; Nagatsu I
Brain Res; 1996 May; 722(1-2):181-4. PubMed ID: 8813364
[TBL] [Abstract][Full Text] [Related]
10. In vivo assessment of dopamine and norepinephrine release in rat neocortex: gas chromatography-mass spectrometry measurement of 3-methoxytyramine and normetanephrine.
Wood PL; Kim HS; Altar CA
J Neurochem; 1987 Feb; 48(2):574-9. PubMed ID: 3794722
[TBL] [Abstract][Full Text] [Related]
11. Determination of 3-methoxytyramine in rat brain by HPLC with electrochemical detection and its correlation with dopamine function after administration of a monoamine oxidase inhibitor and L-3,4-dihydroxyphenylalanine.
Davies CL; Heal DJ
J Neurochem; 1986 Dec; 47(6):1919-23. PubMed ID: 3772383
[TBL] [Abstract][Full Text] [Related]
12. Different effects of monoamine oxidase inhibition on MPTP depletion of heart and brain catecholamines in mice.
Fuller RW; Hemrick-Luecke SK; Kindt MV; Heikkila RE
Life Sci; 1988; 42(3):263-71. PubMed ID: 3121972
[TBL] [Abstract][Full Text] [Related]
13. The effects of GBR 12909, a dopamine re-uptake inhibitor, on monoaminergic neurotransmission in rat striatum, limbic forebrain, cortical hemispheres and substantia nigra.
Nissbrandt H; Engberg G; Pileblad E
Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):16-28. PubMed ID: 1663587
[TBL] [Abstract][Full Text] [Related]
14. Catecholamine degradation by monoamine oxidase in locus coeruleus neurons of the rat. An immunohistochemical study.
Kishimoto Y; Geffard M; Arai R
Brain Res; 2000 Mar; 859(2):373-7. PubMed ID: 10719089
[TBL] [Abstract][Full Text] [Related]
15. Vesicular accumulation of dopamine following L-DOPA administration.
Buu NT
Biochem Pharmacol; 1989 Jun; 38(11):1787-92. PubMed ID: 2735936
[TBL] [Abstract][Full Text] [Related]
16. Dopamine sulfoconjugation in the rat brain: regulation by monoamine oxidase.
Buu NT
J Neurochem; 1985 Aug; 45(2):470-6. PubMed ID: 3925084
[TBL] [Abstract][Full Text] [Related]
17. 3-Methoxytyramine and normetanephrine as indicators of dopamine and noradrenaline release in mouse brain in vivo.
Kehr W
J Neural Transm; 1981; 50(2-4):165-78. PubMed ID: 7241115
[TBL] [Abstract][Full Text] [Related]
18. A new and highly sensitive method for measuring 3-methoxytyramine using HPLC with electrochemical detection. Studies with drugs which alter dopamine metabolism in the brain.
Heal DJ; Frankland AT; Buckett WR
Neuropharmacology; 1990 Dec; 29(12):1141-50. PubMed ID: 2293058
[TBL] [Abstract][Full Text] [Related]
19. L-3,4-dihydroxyphenylalanine-induced dopamine release in the striatum of intact and 6-hydroxydopamine-treated rats: differential effects of monoamine oxidase A and B inhibitors.
Wachtel SR; Abercrombie ED
J Neurochem; 1994 Jul; 63(1):108-17. PubMed ID: 8207420
[TBL] [Abstract][Full Text] [Related]
20. Brain dialysis: in vivo metabolism of dopamine and serotonin by monoamine oxidase A but not B in the striatum of unrestrained rats.
Kato T; Dong B; Ishii K; Kinemuchi H
J Neurochem; 1986 Apr; 46(4):1277-82. PubMed ID: 2419508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
